Guilherme S. Ramos - Search Results

Year	Number of Results
2013	1
2015	1
2017	1
2020	2
2021	3
2022	5
2023	1
2024	0

1

Supramolecular assemblies from antimony(V) complexes for the treatment of leishmaniasis.

Demicheli C, Vallejos VMR, Lanza JS, Ramos GS, Do Prado BR, Pomel S, Loiseau PM, Frézard F. Demicheli C, et al. Among authors: ramos gs. Biophys Rev. 2023 Jun 6;15(4):751-765. doi: 10.1007/s12551-023-01073-6. eCollection 2023 Aug. Biophys Rev. 2023. PMID: 37681109 Free PMC article. Review.

2

Liposomal Amphotericin B for Treatment of Leishmaniasis: From the Identification of Critical Physicochemical Attributes to the Design of Effective Topical and Oral Formulations.

Frézard F, Aguiar MMG, Ferreira LAM, Ramos GS, Santos TT, Borges GSM, Vallejos VMR, De Morais HLO. Frézard F, et al. Among authors: ramos gs. Pharmaceutics. 2022 Dec 28;15(1):99. doi: 10.3390/pharmaceutics15010099. Pharmaceutics. 2022. PMID: 36678729 Free PMC article. Review.

3

Risk of falls using the Biodex Balance System in non-faller patients with Parkinson Disease.

Ramos GS, Silva-Batista C, Palma BP, Ugrinowitsch C, Cunha TFD. Ramos GS, et al. Somatosens Mot Res. 2022 Jun-Dec;39(2-4):111-115. doi: 10.1080/08990220.2021.2018295. Epub 2021 Dec 21. Somatosens Mot Res. 2022. PMID: 34930080

4

Nanoassemblies from Amphiphilic Sb Complexes Target Infection Sites in Models of Visceral and Cutaneous Leishmaniases.

Lanza JS, Vallejos VMR, Ramos GS, de Oliveira ACB, Demicheli C, Rivas L, Pomel S, Loiseau PM, Frézard F. Lanza JS, et al. Among authors: ramos gs. Pharmaceutics. 2022 Aug 21;14(8):1743. doi: 10.3390/pharmaceutics14081743. Pharmaceutics. 2022. PMID: 36015369 Free PMC article.

5

Comparative evaluation of meglumine antimoniate encapsulated in a mixture of conventional and PEGylated liposomes and immunotherapy using an anti-canine IL-10 receptor-blocking monoclonal antibody on canine visceral leishmaniasis.

Cardoso JMO, Brito RCF, Mathias FAS, Reis LES, Vieira JFP, Ostolin TLVDP, Andrade HM, Ramos GS, Frézard F, Aguiar-Soares RDO, Roatt BM, Reis AB. Cardoso JMO, et al. Mol Immunol. 2022 Jan;141:70-78. doi: 10.1016/j.molimm.2021.11.011. Epub 2021 Nov 20. Mol Immunol. 2022. PMID: 34814056

6

Antileishmanial activity of fullerol and its liposomal formulation in experimental models of visceral leishmaniasis.

Ramos GS, Vallejos VMR, Ladeira MS, Reis PG, Souza DM, Machado YA, Ladeira LO, Pinheiro MBV, Melo MN, Fujiwara RT, Frézard F. Ramos GS, et al. Biomed Pharmacother. 2021 Feb;134:111120. doi: 10.1016/j.biopha.2020.111120. Epub 2020 Dec 17. Biomed Pharmacother. 2021. PMID: 33341671 Free article.

7

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes.

Ramos GS, Vallejos VMR, Borges GSM, Almeida RM, Alves IM, Aguiar MMG, Fernandes C, Guimarães PPG, Fujiwara RT, Loiseau PM, Ferreira LAM, Frézard F. Ramos GS, et al. Pharmaceutics. 2022 May 5;14(5):989. doi: 10.3390/pharmaceutics14050989. Pharmaceutics. 2022. PMID: 35631575 Free PMC article.

8

Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.

Dos Santos CCP, Ramos GS, De Paula RC, Faria KF, Moreira POL, Pereira RA, Melo MN, Tafuri WL, Demicheli C, Ribeiro RR, Azevedo EG, Do Monte-Neto R, Da Silva SM, Frézard F. Dos Santos CCP, et al. Among authors: ramos gs. Antimicrob Agents Chemother. 2020 Jun 23;64(7):e00234-20. doi: 10.1128/AAC.00234-20. Print 2020 Jun 23. Antimicrob Agents Chemother. 2020. PMID: 32284386 Free PMC article.

9

Amphiphilic Antimony(V) Complexes for Oral Treatment of Visceral Leishmaniasis.

Fernandes FR, Ferreira WA, Campos MA, Ramos GS, Kato KC, Almeida GG, Corrêa JD Junior, Melo MN, Demicheli C, Frézard F. Fernandes FR, et al. Among authors: ramos gs. Antimicrob Agents Chemother. 2013 Sep;57(9):4229-4236. doi: 10.1128/AAC.00639-13. Epub 2013 Jun 24. Antimicrob Agents Chemother. 2013. PMID: 23796930 Free PMC article.

10

Gadolinium(III) Complexes with N-Alkyl-N-methylglucamine Surfactants Incorporated into Liposomes as Potential MRI Contrast Agents.

Silva SR, Duarte ÉC, Ramos GS, Kock FV, Andrade FD, Frézard F, Colnago LA, Demicheli C. Silva SR, et al. Bioinorg Chem Appl. 2015;2015:942147. doi: 10.1155/2015/942147. Epub 2015 Aug 10. Bioinorg Chem Appl. 2015. PMID: 26347596 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

11 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year